Psoriasis Clinical Trials in San Antonio

Showing 141-160 of 169 trials

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

NCT00504270

This study will investigate the safety, efficacy and pharmacokinetics of R3421 in patients with moderate to severe chronic plaque psoriasis. Patients will be randomized to one of 3 treatment groups to receive once daily oral treatment with a)R3421 20mg, b)R3421 120mg, or c)placebo. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

Psoriasis

Hoffmann-La Roche66 participantsStarted Jul 2007

Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States • Santa Monica, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Tofacitinib Ointment For Chronic Plaque Psoriasis

NCT01831466

The study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis. Two dose strengths of tofacitinib ointment (20 mg/g and 10 mg/g) applied once or twice daily are being tested. The safety and effectiveness of tofacitinib ointment used for 12 weeks will be compared to the safety and effectiveness of placebo ointment (vehicle) used for 12 weeks.

Psoriasis VulgarisPsoriasis

Pfizer476 participantsStarted May 2013

Hot Springs, Arkansas, United States • Bakersfield, California, United States • Irvine, California, United States +51 more locations

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Tofacitinib Ointment For Chronic Plaque Psoriasis

Psoriasis Trials in Other Cities

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Continuation Study in Moderate to Severe Psoriasis

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

An Exploratory Genetic Study in Participants With Psoriasis

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Randomized Study of PH-10 for Psoriasis

Other Conditions in San Antonio